← back to search

Kenneth F. Bradstock

The University of Sydney · AU
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, and Immunotherapy and Immune Responses.
h-index
46
citations
6,692
works
224
NIH funding
primary concept
email

Recent publications

Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase
Leukemia & lymphoma/Leukemia and lymphoma 2023cited by 1position: middledoi
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
Blood Advances 2020cited by 152position: middledoi
Expanded Phenotypic and Genetic Heterogeneity in the Clinical Spectrum of FPD-AML: Lymphoid Malignancies and Skin Disorders Are Common Features in Carriers of Germline RUNX1 Mutations
Blood 2016cited by 4position: middledoi
Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation 2015cited by 64position: firstdoi
G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent
Cytokine & Growth Factor Reviews 2014cited by 301position: lastdoi
Peripheral Blood Hematopoietic Stem Cells for Transplantation of Hematological Diseases from Related, Haploidentical Donors after Reduced-Intensity Conditioning
Biology of Blood and Marrow Transplantation 2014cited by 139position: middledoi
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia
Leukemia & lymphoma/Leukemia and lymphoma 2014cited by 123position: middledoi
Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing <i>MYC</i> Expression
Cancer Research 2014cited by 74position: middledoi
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
The Lancet Infectious Diseases 2013cited by 221position: middledoi
Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice
Experimental Hematology 2012cited by 75position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Linda J. Bendall · Nottingham University Hospitals NHS Trust3 papers (2012–2014)John Kwan · Westmead Hospital2 papers (2014–2015)Angela Bayley · Westmead Hospital1 papers (2015–2015)Ghulam J. Mufti · King's College London1 papers (2014–2014)Kavita Raj · Royal London Hospital1 papers (2014–2014)Michael Osborn · Hospital for Sick Children1 papers (2023–2023)John J. Moore · UNSW Sydney1 papers (2013–2013)Aileen Dela Peňa · The University of Sydney1 papers (2012–2012)Harry Iland · The University of Sydney1 papers (2014–2014)Ian Bilmon · The University of Sydney1 papers (2015–2015)Daochen Tong · Westmead Institute for Medical Research1 papers (2014–2014)Adrian R Tramontana · The University of Melbourne1 papers (2013–2013)Catriona Halliday · The University of Sydney1 papers (2013–2013)David Gottlieb · The University of Sydney1 papers (2015–2015)Colin Walsh · Royal North Shore Hospital1 papers (2023–2023)Ashish Bajel · The University of Melbourne1 papers (2013–2013)Donal P. McLornan · University College Hospital1 papers (2014–2014)Tania C. Sorrell · The University of Sydney1 papers (2013–2013)Toby N. Trahair · New South Wales Department of Health1 papers (2023–2023)Val Gebski · Centre de recherche en Epidémiologie et Santé des Populations1 papers (2015–2015)